Ayeesha Kamran Kamal
Overview
Explore the profile of Ayeesha Kamran Kamal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sajjad A, Farooq Khan A, Jafri L, Kamal A
BMJ Case Rep
. 2022 Jan;
14(12).
PMID: 34972772
No abstract available.
2.
Waheed S, Kalsekar A, Kamal A, Bryan N, Mian A
Emerg Med Int
. 2019 Jul;
2019:9206948.
PMID: 31285918
Introduction: Acute stroke incites an inflammatory reaction in the brain's microvasculature, activating formation of nitric oxide oxidative metabolites, nitrate and nitrite (NOx, collectively), measurable in plasma. Our objectives were to...
3.
Kamal A, Khalid W, Zulfiqar M, Muqeet A, Zaidi F, Gowani A, et al.
Int J Stroke
. 2019 Jan;
14(3):NP8-NP10.
PMID: 30681041
No abstract available.
4.
Kamal A, Khalid W, Muqeet A, Jamil A, Farhat K, Gillani S, et al.
PLoS One
. 2018 Dec;
13(12):e0197671.
PMID: 30571697
Background: We developed and tested the effectiveness of a tailored health information technology driven intervention: "Talking Prescriptions" (Talking Rx) to improve medication adherence in a resource challenged environment. Methods: We...
5.
Awan S, Shafqat S, Kamal A, Sonawalla A, Siddiqui S, Siddiqui F, et al.
BMC Res Notes
. 2017 Nov;
10(1):545.
PMID: 29096694
Objectives: The burden of neurological diseases in developing countries is rising although little is known about the epidemiology and clinical pattern of neurological disorders. The objective of this study was...
6.
Khalid W, Rozi S, Ali T, Azam I, Mullen M, Illyas S, et al.
BMC Neurol
. 2016 Dec;
16(1):250.
PMID: 27912744
Background: There is very little information about the quality of life (QOL) of stroke survivors in LMIC countries with underdeveloped non communicable health infrastructures, who bear two thirds of the...
7.
Gowani A, Ahmed H, Khalid W, Muqeet A, Abdullah S, Khoja S, et al.
BMC Res Notes
. 2016 May;
9:282.
PMID: 27215828
Background: Non-communicable diseases (NCD) are the leading causes of death globally. In Pakistan, they are among the top ten causes of mortality, especially in the productive age group (30-69 years)....
8.
Kamal A, Muqeet A, Farhat K, Khalid W, Jamil A, Gowani A, et al.
Trials
. 2016 Mar;
17(1):121.
PMID: 26944938
Background: Vascular disease, manifesting as myocardial infarction and stroke, is a major cause of morbidity and mortality, especially in low- and middle-income countries. Current estimates are that only one in...
9.
Kamal A, Khoja A, Usmani B, Muqeet A, Zaidi F, Ahmed M, et al.
Trials
. 2016 Jan;
17:52.
PMID: 26818913
Background: Two thirds of the global mortality of stroke is borne by low and middle income countries (LMICs). Pakistan is the world's sixth most populous country with a stroke-vulnerable population...
10.
Cottler L, Zunt J, Weiss B, Kamal A, Vaddiparti K
Nature
. 2015 Nov;
527(7578):S207-13.
PMID: 26580329
The global burden of neurological, neuropsychiatric, substance-use and neurodevelopmental disorders in low- and middle-income countries is worsened, not only by the lack of targeted research funding, but also by the...